
In today’s briefing:
- Metaplanet (3350) | From Tokyo to the U.S?
- Nittobo (3110 JP): Scarcity Premium in AI Substrates with Strong Earnings Visibility
- IBIDEN Co., Ltd.: AI Substrate Leader with Strong Growth, Expanding Moat, and Valuation Upside
- Formosa Prosonic: Trading at Cash
- TSMC (2330.TT; TSM.US): Will Rapidus Threaten TSMC’s 2nm Market? We Think It’s Too Early to Say (II)
- PVRINOX IN: Tactical Bet – Strong Content Pipeline Can Translate to near Term Outperformance
- I’d Stay Far Away from UnitedHealth.
- How Kontoor Brands Is Building a Fashion Empire by Blending Efficiency, Tech, & Global Reach!
- Taiwan Tech Weekly: 1.4nm Slips from Samsung’s Grip? Why Intel May Be TSMCs Sole Next Gen Competitor
- Bumble Inc. Is Improving Its AI Matchmaking Capabilities—Can It Help Consumers Get Past The Swiping Fatigue?

Metaplanet (3350) | From Tokyo to the U.S?
- Metaplanet has raised over $500 million via stock acquisition rights, using proceeds to repay short-term bonds and expand its Bitcoin holdings.
- Evo Fund, the main financier, has exercised 54 million shares and likely profited over $100 million through a share borrowing arrangement and market arbitrage.
- A $5 billion capital injection into its U.S. subsidiary hints at potential U.S listing (?), with an EGM scheduled for September to clarify strategic direction.
Nittobo (3110 JP): Scarcity Premium in AI Substrates with Strong Earnings Visibility
- Revenue grew steadily over five years, supported by demand for high-performance glass cloth used in advanced semiconductor packaging.
- It controls a critical bottleneck in AI substrates and is expanding capacity with ¥80B capex through FY28.
- EPS is set to rise 46% by FY28, with fwd PE at 9.3x and EV/EBITDA at 5.1x, suggesting scope for valuation re-rating.
IBIDEN Co., Ltd.: AI Substrate Leader with Strong Growth, Expanding Moat, and Valuation Upside
- Over FY21–25, IBIDEN has delivered strong revenue and profit growth, with operating income rising ~44% and EPS growing ~34% despite cyclical pressures.
- The company commands a dominant ~70–85% market share in AI/server IC substrates, led by Nvidia demand, and is expanding capacity at Ono and Gama plants to sustain leadership.
- With a 17–21% EPS CAGR forecast and trading at ~26× P/E—well below high-growth peers—IBIDEN offers a compelling blend of quality growth and relative valuation comfort.
Formosa Prosonic: Trading at Cash
- Formosa Prosonic: Asymmetrical Risk Reward for investing as operating business is being priced for nothing
- The company is leading manufacturer of industrial solutions focused for audio and electronic musical products
- It has significant client concentration risks with Top 3 customers accounting for 92% of Revenues.
TSMC (2330.TT; TSM.US): Will Rapidus Threaten TSMC’s 2nm Market? We Think It’s Too Early to Say (II)
- Japan’s Fujitsu Ltd (6702 JP) is currently developing a 2nm CPU named “MONAKA” (link). The CPU is planned to be manufactured by Taiwan Semiconductor (TSMC) – ADR (TSM US).
- Rapidus has to deal with high technical barriers, tight timelines, heavy R&D costs, market and profitability challenges.
- Talent shortage in Japan: A lingering pain for the Semiconductor industry
PVRINOX IN: Tactical Bet – Strong Content Pipeline Can Translate to near Term Outperformance
- FY25 was Indian boxoffice’s worst performance ever (ex-covid). FY26 has started strong with multiple hits and June-Dec lineup boasts multiple action-oriented and sequel movies; genres that are witnessing high occupancy.
- Company has strengthened its balance sheet post ‘INOX’ acquisition despite the revenue slump. fixed cost/screen is flat vs FY20 at 2cr while average ticket prices have grown at 5% CAGR
- Comfortable entry level valuation (10.5x TTM EBITDA vs global peers CNK/AMC at 12/35x) supported by improved operational execution position the stock as a near term re-rating candidate.
I’d Stay Far Away from UnitedHealth.
Much of UnitedHealth’s business is just freeriding the US healthcare system.
To some extent it could even be called parasitic. 40% of its revenues come from government programs.
The most important one is Medicare Advantage (MA), which was originally designed to lower costs through the use of private carriers and their competition.
How Kontoor Brands Is Building a Fashion Empire by Blending Efficiency, Tech, & Global Reach!
- Kontoor Brands, a prominent name in the fashion industry known for its Wrangler and Lee brands, has recently shared its financial results for the first quarter of 2025.
- The company made notable headway with the impending acquisition of Helly Hansen, which is anticipated to bring substantial benefits in terms of revenue growth, earnings, and cash flow.
- The acquisition is expected to be finalized by the end of May and will likely offer opportunities for expansion and operational synergy.
Taiwan Tech Weekly: 1.4nm Slips from Samsung’s Grip? Why Intel May Be TSMCs Sole Next Gen Competitor
- Samsung’s 1.4nm Technology Delay Highlights Potential That Intel Could End Up the Only Viable Alternative to TSMC — Maintain Structural Long for TSMC
- Micron Results Today Will Provide Insight Into Resilience of AI/HPC Equipment Demand
- TechChain Insights: Himax Threatened by China Auto Chip Push? CPO Tech with TSMC Remains Bright Spot
Bumble Inc. Is Improving Its AI Matchmaking Capabilities—Can It Help Consumers Get Past The Swiping Fatigue?
- Bumble Inc.’s recent financial performance and strategic direction provide an intricate picture of potential future opportunities and challenges.
- The earnings call highlighted several key themes.
- Bumble is actively working to transition its focus from expansion via performance marketing to enhancing user experience and match quality.